Ketamine Treatment for Depression: Rapid Relief Amidst Patient Fears
- A psychiatrist has highlighted the rapid efficacy of ketamine in treating depression, noting that symptoms can disappear within a few hours of administration, according to a report by...
- The report emphasizes a significant disparity between the clinical results of the treatment and the perceptions of the patients.
- This apprehension is largely attributed to the drug's reputation outside of a clinical setting.
A psychiatrist has highlighted the rapid efficacy of ketamine in treating depression, noting that symptoms can disappear within a few hours of administration, according to a report by the Lithuanian news outlet 15min.lt published on May 30, 2026.
The report emphasizes a significant disparity between the clinical results of the treatment and the perceptions of the patients. Despite the speed at which the medication can alleviate depressive symptoms, many individuals express fear or hesitation toward the therapy.
This apprehension is largely attributed to the drug’s reputation outside of a clinical setting. The psychiatrist noted that the fear stems from the association of ketamine with recreational misuse and its effects as a dissociative agent, which can lead patients to view the treatment with suspicion or alarm.
The speed of the treatment’s impact is a primary point of distinction from traditional psychiatric care. Conventional antidepressant medications typically require several weeks of consistent use before a patient experiences a therapeutic effect or a noticeable improvement in mood.
In contrast, the psychiatrist stated that ketamine can produce results in a matter of hours. This rapid onset is particularly significant for patients who have not responded to other forms of treatment or those experiencing acute symptoms that require immediate intervention.
The report indicates that the treatment is conducted under strict medical supervision. This clinical environment is necessary to manage the patient’s experience and ensure safety during the process, further distinguishing the medical application from the illicit use that contributes to patient fear.
By addressing the stigma and providing education on the nature of the clinical application, the psychiatrist suggests that more patients could benefit from the rapid symptom relief offered by the treatment.
